12:00 AM
Jun 12, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Human growth hormone (hGH): Began Trials

Cangene Corp. (TSE:CNJ), Mississauga, Ontario
Product: Human growth hormone (hGH)
Business: Metabolic, Generics
Therapeutic category: Hormone replacement
Target: hGH receptors
Description: Subsequent...

Read the full 87 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >